Phase 2 trial of irinotecan and thalidomide in adults with recurrent anaplastic glioma.
Giglio P; Dhamne M; Hess KR; Gilbert MR; Groves MD; Levin VA; Kang SL; Ictech SE; Liu V; Colman H; Conrad CA; Loghin M; de Groot J; Yung WK; Puduvalli VK; Cancer, 2012, vol. 118, issue 14, p 3599, ISSN 10970142. ISBN 10970142.

Full Text Resources Located for this Citation

View article on EBSCOhost(Login required)
View article via CrossRef